· Hyperprolactinemia. E22.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM E22.1 became effective on October 1, 2021. This is the American ICD-10-CM version of E22.1 - other international versions of ICD-10 E22.1 may differ.
Search Page 1/1: prolactin levels. 22 result found: ICD-10-CM Diagnosis Code R74.01 [convert to ICD-9-CM] Elevation of levels of liver transaminase levels. Elevation of levels of alanine transaminase (ALT); Elevation of levels of aspartate transaminase (AST) ICD-10-CM Diagnosis Code R74.01. Elevation of levels of liver transaminase levels.
ICD-10-CM Diagnosis Code E22.1 [convert to ICD-9-CM] Hyperprolactinemia. Hyperprolactinemia (high prolactin hormone level); code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5) ICD-10-CM Diagnosis Code E22.1. Hyperprolactinemia. 2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code. Use Additional.
ICD-10-CM Diagnosis Code R97.0 [convert to ICD-9-CM] Elevated carcinoembryonic antigen [CEA] Elevated cea; High carcinoembryonic antigen level. ICD-10-CM Diagnosis Code R97.0. Elevated carcinoembryonic antigen [CEA] 2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code. ICD-10-CM Diagnosis Code R74.0.
Hyperprolactinemia (high prolactinhormone level); code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
activity, mountain climbing (Y93.31); Activity, walking, marching and hiking on level or elevatedterrain
code for adverse effect, if applicable, to identify drug (T36-T50with fifth or sixth character 5)
activity, hiking on level or elevated terrain (Y93.01)
Hypersecretion of prolactin can be caused by pituitary adenomas, hypothalamic disease, breast or chest wall stimulation, renal failure or hypothyroidism. A number of drugs, including many antidepressants, are also common causes of abnormally elevated prolactin levels. ...
During pregnancy and postpartum lactation, serum prolactin can increase 10- to 20-fold. Exercise, stress, and sleep also cause transient increases in prolactin levels. Consistently elevated serum prolactin levels (>30 ng/mL), in the absence of pregnancy and postpartum lactation, are indicative of hyperprolactinemia. Hypersecretion of prolactin can be caused by pituitary adenomas, hypothalamic disease, breast or chest wall stimulation, renal failure or hypothyroidism. A number of drugs, including many antidepressants, are also common causes of abnormally elevated prolactin levels. ...
In addition, elevated serum prolactin concentrations are caused by a number of pharmaceuticals (eg, dibenzodiazepines, phenothiazine), TRH, and estrogen. 1-3 The release of prolactin is inhibited by dopamine, L-dopa, and ergotamine derivatives.
When determining prolactin, it should be remembered that the measured concentration is dependent upon when the blood sample was taken, since the secretion of prolactin occurs in episodes and is also subject to a 24-hour cycle. The release of prolactin is promoted physiologically by suckling and stress.
Antipsychotic drugs may elevate serum prolactin. Antipsychotics block dopamine, thereby elevating serum prolactin levels. Hyperprolactinemia is present in many patients receiving neuroleptics with an occasional patient developing amenorrhea, galactorrhea, and/or decreased libido. Amoxapine, a dibenzoxazepine type of tricyclic with antidepressant and antipsychotic characteristics, has been found to cause galactorrhea and oligomenorrhea with hyperprolactinemia. Amoxapine may have a dopamine blocking action. 7 The prolactin level may rise significantly but only briefly. Point prolactin level determinations during therapy may be within normal range while total integrated 24-hour secretion is significantly increased. It has been recommended that patients who develop amenorrhea and/or galactorrhea during neuroleptic therapy should be observed regularly for possible emergence of a pituitary tumor.